| abstract |
The present invention generally relates to antibodies that bind to CD147, activatable antibodies that bind to CD147, and to make these antibodies and activatable antibodies, and use in a variety of therapeutic, prophylactic and diagnostic contexts. On how to do. In some embodiments, the CD147 antibody and CD147 activatable antibody bind to human and cynomolgus CD147. |